We recently held our first webinar of 2023, ‘Supporting mutagenic impurity and degradant risk assessment using an in silico approach’.
This free-to-attend webinar featured talks from Dr. Andreas Broehl, Laboratory Head at Bayer Pharmaceuticals, and Lhasa Limited Senior Scientist, Dr. Ash Ali.
In this exciting virtual event, we explored how our in silico software solution Zeneth, can help support your nitrosamine risk assessments and enhance your degradation workflow.
Lhasa Senior Application Scientist, Maggie Coombs, will provided a short Zeneth software demonstration which was followed by a live Q&A.
If you would like a copy of the slides and webinar recording, please reach out to our marketing team.